| 000 | 01752 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513081343.0 | ||
| 264 | 0 | _c19930505 | |
| 008 | 199305s 0 0 eng d | ||
| 022 | _a0004-8682 | ||
| 024 | 7 |
_a10.1111/j.1445-2197.1993.tb00029.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRosenthal, M A | |
| 245 | 0 | 0 |
_aPrimary cerebral lymphoma: an argument for the use of adjunctive systemic chemotherapy. _h[electronic resource] |
| 260 |
_bThe Australian and New Zealand journal of surgery _cJan 1993 |
||
| 300 |
_a30-2 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma _xdrug therapy |
| 650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xdrug therapy |
| 650 | 0 | 4 |
_aLymphoma, Large-Cell, Immunoblastic _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPrednisolone _xadministration & dosage |
| 650 | 0 | 4 | _aRadiotherapy Dosage |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aVictoria _xepidemiology |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aSheridan, W P | |
| 700 | 1 | _aGreen, M D | |
| 700 | 1 | _aLiew, K | |
| 700 | 1 | _aFox, R M | |
| 773 | 0 |
_tThe Australian and New Zealand journal of surgery _gvol. 63 _gno. 1 _gp. 30-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1445-2197.1993.tb00029.x _zAvailable from publisher's website |
| 999 |
_c8465726 _d8465726 |
||